FORM 5
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ] Form 3 Holdings Reported
[ ] Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

                                                                                  

OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response...
1.0
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ross Julian T

2. Issuer Name and Ticker or Trading Symbol

OxySure Systems Inc [OXYS]

5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CEO, PRESIDENT, SECRETARY

(Last)          (First)          (Middle)

10880 JOHN W. ELLIOT DRIVE,  SUITE 600

3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY)
12/31/2012 
(Street)

FRISCO, TX 75033

(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person


Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Amount (A) or (D) Price
Common Stock                 14125761.0000   I   Held by JTR Investments, Limited  
Common Stock                 400000.0000   I   Held by The Ross Family Trust  
Common Stock                 356474.0000   D  
 
Common Stock                 335880.0000   I   Held by Afritex Medical Products (Pty) Ltd.  
Common Stock                 116182.0000   I   Held by Spouse  

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YYYY)
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (right to buy)   $0.2500                 1/15/2005   (2) 12/15/2022   (3) Common stock   1177488.0000     1177488.0000   (1) D  
 
Options (right to buy)   $0.7200                 3/1/2005   (2) 3/1/2019   (3) Common stock   81500.0000     81500.0000   I   Held by Spouse  
Warrants   $2.5000                 3/26/2010   3/26/2015   Common stock   270000.0000     270000.0000   I   Held by Afritex Medical Products (Pty) Ltd.  
Warrants   $0.0100                 9/30/2008   9/30/2013   Common stock   7000.0000     7000.0000   I   Held by Spouse  

Explanation of Responses:
( 1)  Comprises vested options issued pursuant to the Company's 2004 Stock Option Plan, and vesting routinely pursuant to the provisions of employment agreements.
( 2)  Represents the earliest date(s) any options became exercisable.
( 3)  Represents the latest date(s) any vested options expire.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ross Julian T
10880 JOHN W. ELLIOT DRIVE
SUITE 600
FRISCO, TX 75033
X X CEO, PRESIDENT, SECRETARY

Signatures
/s/Julian T Ross 2/13/2013
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.